Would Wider Access to GLP-1s Throttle Addiction?
Jan 31, 2025•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drugs like Ozempic show potential to help those with addiction with little downside risk. How quickly can their availability be expanded? Nicholas Reville of CASPR makes his case.
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android